Point72 Asset Management
BSX icon

Point72 Asset Management’s Boston Scientific BSX Stock Holding History

Point72 Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132M Buy
2,110,900
+1,832,300
+658% +$147M 0.17% 120
2025
Q4 		$26.6M Sell
278,600
-666,800
-71% -$65.4M 0.03% 724
2025
Q3 		$92.3M Buy
945,400
+934,200
+8,341% +$96.7M 0.15% 139
2025
Q2 		$1.2M Sell
11,200
-193,900
-95% -$19.6M ﹤0.01% 1485
2025
Q1 		$20.7M Buy
205,100
+197,200
+2,496% +$19.9M 0.05% 444
2024
Q4 		$706K Sell
7,900
-50,400
-86% -$4.44M ﹤0.01% 1569
2024
Q3 		$4.89M Buy
58,300
+31,600
+118% +$2.49M 0.01% 881
2024
Q2 		$2.06M Buy
26,700
+14,100
+112% +$1.03M 0.01% 1089
2024
Q1 		$863K Buy
+12,600
New +$810K ﹤0.01% 1497
2023
Q3 		– Sell
-22,700
Closed -$1.23M – 2493
2023
Q2 		$1.23M Buy
+22,700
New +$1.19M ﹤0.01% 1111
2023
Q1 		– Sell
-16,100
Closed -$745K – 2249
2022
Q4 		$745K Hold
16,100
– – ﹤0.01% 1091
2022
Q3 		$624K Hold
16,100
– – ﹤0.01% 1131
2022
Q2 		$600K Buy
+16,100
New +$655K ﹤0.01% 1157
2017
Q1 		– Sell
-500,000
Closed -$10.8M – 819
2016
Q4 		$10.8M Buy
+500,000
New +$10.9M 0.08% 297
2016
Q1 		– Sell
-650,000
Closed -$12M – 734
2015
Q4 		$12M Buy
+650,000
New +$11.6M 0.1% 243
2015
Q1 		– Sell
-750,000
Closed -$9.94M – 688
2014
Q4 		$9.94M Buy
+750,000
New +$9.59M 0.07% 329

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asset Management's BSX Position: Q1 2026 in Review

Point72 Asset Management increased its Boston Scientific (BSX) stake by 51% in Q1 2026, buying an estimated $100M and bringing the position to 3,687,315 shares worth $231M. The position accounts for 0.3% of the portfolio, ranked #41.

Point72 Asset Management first reported a position in BSX in Q3 2014 and has held it in 40 quarters since. The position peaked at $339M in Q3 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Point72 Asset Management held 3,687,315 shares of Boston Scientific worth $231M as of Q1 2026.
  • Point72 Asset Management bought 1,252,752 Boston Scientific shares in Q1 2026, an estimated $100M.
  • Boston Scientific made up 0.3% of Point72 Asset Management's portfolio in Q1 2026, its #41 holding.
  • Point72 Asset Management first reported a position in Boston Scientific in Q3 2014 and has held it in 40 quarters since.
  • Point72 Asset Management's Boston Scientific position peaked at $339M in Q3 2023.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.